Synonyms: TFT | trifluorothymidine
trifluridine is an approved drug (Japan, FDA (2015), EMA (2016))
Compound class:
Synthetic organic
Comment: Trifluridine was originally approved by the US FDA in 1980, and was used for its antiviral effects (marketed as Vitroptic®). The drug is now being investigated for its antineoplastic (cytotoxic) effect.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (Japan, FDA (2015), EMA (2016)) |
IUPAC Name |
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione |
International Nonproprietary Names | |
INN number | INN |
4146 | trifluridine |
Synonyms |
TFT | trifluorothymidine |
Database Links | |
ChEMBL Ligand | CHEMBL1129 |
DrugBank Ligand | DB00432 |
DrugCentral Ligand | 2743 |
GtoPdb PubChem SID | 252166897 |
PubChem CID | 6256 |
Search Google for chemical match using the InChIKey | VSQQQLOSPVPRAZ-RRKCRQDMSA-N |
Search Google for chemicals with the same backbone | VSQQQLOSPVPRAZ |
Search PubMed clinical trials | trifluridine |
Search PubMed titles | trifluridine |
Search PubMed titles/abstracts | trifluridine |
UniChem Compound Search for chemical match using the InChIKey | VSQQQLOSPVPRAZ-RRKCRQDMSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | VSQQQLOSPVPRAZ-RRKCRQDMSA-N |